INDUSTRY WORKSHOP: TDM by LC/MS: From Single to Multiplex and expansion to Novel Drugs
Tracks
Track 3
| Wednesday, September 24, 2025 |
| 12:30 PM - 1:25 PM |
| Grand Copthorne Waterfront Hotel - Waterfront Ballroom III |
Overview
Delivered by: Waters Pacific
Details
The scope of the talk is the use of liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the quantification of Therapeutic Drugs. The subject matter will be covered using a timeline from the initial beginnings of LC-MS/MS for the quantification of immunosuppressive drugs through to its expansion to quantifying chemotherapeutic and psychotropic drugs and multiplexing. The final section will look to the future and how LC-MS/MS quantitative assays will be developed during clinical trials of personalized medicines including monoclonal antibodies and modern therapeutics.
Speaker
Mr Fionn Quinlan
Clinical Marketing Head
Waters Corp Clinical Unit
TDM by LC/MS: From Single to Multiplex and expansion to Novel Drugs
Biography
Fionn Quinlan is the Asia Clinical Market Manager for Waters Corporation and is based in Taiwan.
Since Fionn completed his post graduate studies in Dublin City University and Trinity College Dublin in the fields of molecular genetics, he has been continuously involved in the life science, diagnostics and forensic field for over 20 years.
Fionn works closely with leading hospitals, national reference laboratories, universities and forensic labs throughout Asia supporting the education and awareness of LCMS applications.
He is a serving member of the Asia Pacific Federation of Clinical Biochemistry commercial committee. His focus areas are New Born Screening, Therapeutic Drug Monitoring, Endocrinology, Forensic and Clinical Toxicology.
